ArticleAntonie van Leeuwenhoek2026
Computational identification of inhibitors from Aegle marmelos leaf extract targeting ergosterol biosynthesis ERG4/ERG24 enzyme and serine proteases for combatting mancozeb-resistant Fusarium.
Article in Antonie van Leeuwenhoek, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fusarium species are major phytopathogens responsible for economically significant diseases such as vascular wilt, root rot, and necrosis in diverse crops. The increasing incidence of mancozeb-resistant strains has complicated disease management, underscoring the need for sustainable alternative or complementary strategies. In this study, phytochemicals from Aegle marmelos were evaluated against Fusarium spp. using an integrated computational approach combining molecular docking and molecular dynamics (MD) simulations. The ergosterol biosynthesis ERG4/ERG24 family enzyme (ERG) and serine protease (SEP) were selected for the first time as molecular targets to assess antifungal potential. Lupeol, not previously investigated in this context, was subjected to a 100 ns MD simulation to evaluate the stability and dynamic behaviour of the protein-ligand complexes. The simulation results revealed a good stability in the formation of complexes with lupeol, a finding that was further validated through Principal Component Analysis (PCA) and MMPBSA calculations. The ΔG binding values calculated by MMPBSA for the lupeol-ERG and lupeol-SEP interactions were found to be - 33.06 ± 3.10 and - 19.60 ± 3.43 kcal/mol, respectively. Complementary in vitro assays revealed that the combined application of A. marmelos leaf extract and mancozeb produced the highest inhibition of mycelial growth of Fusarium sp. strain AA1, accompanied by pronounced morphological deformities, including distorted and collapsed conidia. Collectively, this multi-level validation establishes a novel framework for developing plant-based antifungal strategies to combat mancozeb-resistant Fusarium. Moreover, the synergistic use of plant extract with reduced fungicide dosage offers a sustainable approach that may lower chemical inputs while advancing the development of eco-friendly antifungal strategies for agricultural applications.
Indexed as
Identifiers
42283884What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.